Stanford's 37,000 AI Agents Speed Up Drug Discovery

Stanford researchers created a virtual biotech company powered by 37,000 AI agents that identified which drugs succeed in trials and designed a cancer treatment a major pharmaceutical company independently validated.

The system completed in six hours what would take human teams months, offering hope for faster, smarter drug development.